Response to polysaccharide antigens in patients with ataxia-telangiectasia

Jornal de Pediatria

Volumn 82, Issue 2, 2006, Pages 132-136

  Guerra Maranhão, Maria Cristina ^a   Costa Carvalho, Beatriz T ^a,e   Nudelman, Victor ^b   Barros Nunes, Patrícia ^a   Carneiro Sampaio, Magda M S ^c   Arslanian, Cristina ^c   Nagao Dias, Aparecida T ^d   Solé, Dirceu ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^e Universidade de São Paulo ^*  (Brazil)

Author keywords

Antibody; Ataxia telangiectasia; Humoral immunity; Immunodeficiency; Pneumococcus; Polysaccharide; Streptococcus pneumoniae

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; PNEUMO23; POLYSACCHARIDE ANTIGEN; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; ATAXIA TELANGIECTASIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNIZATION; LUNG INFECTION; MALE; RISK; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ANTIBODIES, BACTERIAL; ATAXIA TELANGIECTASIA; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; VACCINATION;

EID: 33645984272     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1460     Document Type: Article

References (22)

1. Stray-Pedersen A, Jonsson T, Heiberg A, Lindman CR, Widing E, Aaberge IS, et al. The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. Clin Exp Immunol. 2004;137:179-86.
2. Lavin MF, Lederman HM. Chromosomal breakage syndromes associated with immunodeficiency. In: Stiehm ER, Ochs HD, Winkelstein JA. Immunologic disorders in infants & children. 5th ed. Philadelphia: Elsevier/Saunders; 2004. p. 580-7.
3. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268:1749-53.
4. Regueiro JR, Porras O, Lavin M, Gatti RA. Ataxia-telangiectasia. A primary immunodeficiency revisited. Immunol Allergy Clin North Am. 2000;20:177-206.
5. Sanal O, Ersoy F, Yel L, Tezcan I, Metin A, Özyürek H, et al. Impaired IgG antibody production to pneumococcal polysacharides in patients with ataxia-telangiectasia. J Clin Immunol. 1999;19:326-34.
6. Gatti RA, Bick M, Tam CF, Medici MA, Oxelius VA, Holland M, et al. Ataxia-telangiectasia: a multiparameter analysis of eight families. Clin Immunol Immunopathol. 1982;23:501-16.
7. Oxelius VA, Berkel AI, Hanson LA. IgG2 deficiency in ataxia-telangiectasia. N Engl J Med. 1982;306:515-7.
8. Rivat-Peran L, Buriot D, Salier JP, Rivat C, Dumitresco SM, Griscelli C. Immunoglobulins in ataxia-telangiectasia: evidence for IgG4 and igA2 subclass deficiencies. Clin Immunol Immunopathol. 1981;20:99-110.
9. Diagnostic Criteria for Primary Immunodeficiencies. http://www.esid.org.
10. Fujimura MD. Níveis séricos das subclasses de IgG em crianáas normais e nefróticas [tese de doutorado. São Paulo: Universidade de São Paulo; 1991.
11. Sorensen R, Leiva L, Javier III FC, Sacerdote DM, Bradford N, Butler B, et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol. 1998;102:215-21.
12. Waldman TA, McIntire KR. Serum alpha-fetoprotein levels in patients with ataxia telangiectasia. Lancet. 1972;2:1112-5.
13. Lane PJL, Maclennan ICM. Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA. Clin Exp Immunol. 1986;65:427-33.
14. Shackelford PG, Granoff DM, Madassery JV, Scott MG, Nahm MH. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res. 1990;27:16-21.
15. Lopis MJP, Harms G, Hardonik MJ, Timens W. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J Allergy Clin Immunol. 1996;97:1015-24.
16. Grifioen AW, Rijkers GT, Janssens-Korpela P, Zegers BJM. Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect Immnun. 1991;59:1839-45.
17. Barret DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol. 1986;63:127-34.
18. Brandileone MCC, Vieira VSD, Zanella RC, Landgraf IM, Helles CEA, De Escragnole Taunay A, et al. Distribution of serotype of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, Brazil. J Clin Microbiol. 1995;33:2789-91.
19. Sanal O, Ozbas-Gerceker F, Yel L, Ersoy F, Tezcan I, Berckel AI, et al. Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia. Turk J Pediatr. 2004;46:208-13.
20. Sanal O, Ersoy F, Tezcan I, Metin A, Turul T, Gariboglu S, et al. Antibody response to a seven-valent pneumococcal conjugated vaccine in patients with ataxia-telangiectasia. J Clin Immunol. 2004;24:411-7.
21. Coutinho G, Mitui M, Campbell C, Costa Carvalho BT, Nahas S, Sun X, et al. Five haplotypes account for fifty-five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: seven new mutations. Am J Med Genet A. 2004;126:33-40.
22. Khanna KK, Yan J, Watters D, Hobson K, Beamish H, Spring K, et al. Defective signaling through the B cell antigen receptor in Epstein-Barr virus transformed ataxia-telangiectasia cells. J Biol Chem. 1997;272:9489-95.